Skip to main content

Table 1 Characteristics of patients in the cancer and control groups

From: The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study

Characteristics

Before matching

After matching

Cancer group (n = 51)

Control group (n = 5497)

P value

Cancer group (n = 51)

Control group (n = 204)

P value

Age, median

47

35

< 0.0001

47

46

0.69

Female gender, n (%)

49, 96.08

4930, 89.68

0.2055

49, 96.08

192,94.12

0.74

Age at SLE diagnosis, median

41

33

0.0024

41

39

0.96

Disease course of SLE, median

60

6

< 0.0001

60

60

0.92

Hypertension

5, 9.80%

199, 3.620%

0.0195

5, 9.80%

15, 7.35%

0.56

Diabetes mellitus

5, 9.80%

189, 3.438%

0.0375

5, 9.80%

14, 6.86%

0.55

Dyslipidemia

8, 15.38%

494, 8.18%

0.0969

8, 15.38%

28, 13.72%

0.72